tetano
Editor, Senior Moderator
Antiviral Res. 2013 Aug 28. pii: S0166-3542(13)00224-6. doi: 10.1016/j.antiviral.2013.08.016. [Epub ahead of print]
Clinical management and infection control of SARS: lessons learned.
Cheng VC, Chan JF, To KK, Yuen KY.
Source
Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China; Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
Abstract
The outbreak of severe, acute respiratory syndrome (SARS) in 2003 was the first emergence of an important human pathogen in the 21st century. Responding to the epidemic provided clinicians with extensive experience in diagnosing and treating a novel respiratory viral disease. In this article, we review the experience of the SARS epidemic, focusing on measures taken to identify and isolate patients, prevent the transmission of infection to healthcare workers and develop effective therapies. Lessons learned from the SARS epidemic will be especially important in responding to the current emergence of another highly pathogenic human coronavirus, the agent of Middle East respiratory syndrome (MERS), and to the recently emerging H7N9 influenza A virus in China. This paper forms part of a symposium in Antiviral Research on "From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses."
Copyright ? 2013. Published by Elsevier B.V.
KEYWORDS:
Middle East respiratory syndrome, Nosocomial infection, SARS, Severe Acute Respiratory Syndrome
PMID:
23994190
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23994190
Clinical management and infection control of SARS: lessons learned.
Cheng VC, Chan JF, To KK, Yuen KY.
Source
Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, China; Infection Control Team, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
Abstract
The outbreak of severe, acute respiratory syndrome (SARS) in 2003 was the first emergence of an important human pathogen in the 21st century. Responding to the epidemic provided clinicians with extensive experience in diagnosing and treating a novel respiratory viral disease. In this article, we review the experience of the SARS epidemic, focusing on measures taken to identify and isolate patients, prevent the transmission of infection to healthcare workers and develop effective therapies. Lessons learned from the SARS epidemic will be especially important in responding to the current emergence of another highly pathogenic human coronavirus, the agent of Middle East respiratory syndrome (MERS), and to the recently emerging H7N9 influenza A virus in China. This paper forms part of a symposium in Antiviral Research on "From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses."
Copyright ? 2013. Published by Elsevier B.V.
KEYWORDS:
Middle East respiratory syndrome, Nosocomial infection, SARS, Severe Acute Respiratory Syndrome
PMID:
23994190
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/23994190